chartexchange

IBRX CEO Reveals Fresh Anktiva Data After Bladder Cancer Trial Win — Says FDA Filing Is Just Weeks Away

Stocktwits | Nov 17, 2026 1:38 AM EST

ImmunityBio plans to present the full response rates at a medical meeting, showing how much benefit Anktiva added.

Read original article